Govt. set target to increase market share of Ayurveda to three fold by 2022

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Minister of State for AYUSH Shri Shripad Yesso Naik and Minister of State for Culture and Environment and Forest Dr. Mahesh Sharma addressed the inaugural session of the two day ‘National Seminar on Entrepreneurship and Business Development in Ayurveda’ today....

Read More

Sh. Anil Baijal, Lt. Governor of NCT of Delhi conferred upon Gold Medal by DPSRU

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

The 1st Annual convocation of DPSRU was organized on 18th October, 2018 in DPSRU. The Hon’ble Chancellor Sh. Anil Baijal, Lieutant Governor of NCT of Delhi conferred the degrees to M. Pharm., MBA (Pharmaceutical Management) MPH and MHM students of...

Read More

Ayurveda Departments will be opened in the new 19 AIIMS

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Minister of State for AYUSH Shri Shripad Yesso Naik has announced that Ayurveda Departments will be opened in the new 19 AIIMS. He said, work is already on to start Ayurveda Departments in hundred ESIC hospitals under Ministry of Labour....

Read More

Senior Care Conclave – Igniting Industry for India’s Ageing Sector

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

“Corporate leaders across all sectors should explore opportunities of investment in the emerging field of senior care.” This was stated by Smt Anupriya Patel, Minister of State for Health and Family Welfare during her keynote address at the ‘1st Annual...

Read More

Glenmark Pharmaceuticals Announces Decision to Launch Phase 1 Trial in Solid Tumors

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Glenmark Pharmaceuticals, a global pharmaceutical company has announced the decision to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision is driven by recent findings derived from a non-interventional human study utilizing...

Read More

Mylan Receive FDA Approval for YUPELRI™ (revefenacin) in Adults with Chronic Obstructive Pulmonary D

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for YUPELRITM (revefenacin) inhalation solution for the maintenance treatment of...

Read More

DPSRU VC & faculties got awarded in APTICON at Jaipur

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Prof. R.K. Goyal, Vice Chancellor, Delhi Pharmaceutical Sciences and Research University, Awarded Prof. M.L. Schroff Award during 23rd APTICON-2018 held on Oct 5-6, 2018 at Jaipur. Dr. Sushama Talegaonkar Associate Professor, Pharmaceutics and Dr. Mukesh Nandave, Associate Professor in Pharmacology...

Read More

Strides Pharma in pact with Australia’s SUDA

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Bangalore-based company to sell migraine drug SUD-001H in US market Strides Pharma Science (formally Strides Shasun) on Friday said its step-down subsidiary has entered into an exclusive product development, licensing and supply agreement with Australia’s SUDA Pharmaceuticals for its drug...

Read More

Zydus to use pharma background, doctor connect to boost Complan sales

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Sohini Das | Mumbai Zydus Wellness, the personal care arm of pharma major Cadila Healthcare, is planning to use its doctor connect to boost the sales of the acquired brands portfolio of Heinz India. Analysts expect the acquisition to be...

Read More

Ministry of Food Processing Industries issues guidelines for OPERATION GREENS

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Ministry of Food Processing Industries(MoFPI) under Union Minister Smt Harsimrat Kaur Badal has approved the operationalisation strategy for Operation Greens today. Operation Greens was announced in the Budget speech of 2018-19 with an outlay of Rs 500 crores to stabilize...

Read More

Lupin launches generic Atovaquone Oral Suspension USP in the US

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Pharma major Lupin announced the launch of Atovaquone Oral Suspension USP, 750 mg/5 mL having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Atovaquone Oral Suspension USP, 750 mg/5 mL is the generic equivalent...

Read More

FDA grants priority review to Roche’s Tecentriq for treatment of triple-negative breast cancer

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Roche has announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) plus chemotherapy (Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of unresectable...

Read More

MoU signed on India-UK Cancer Research Initiative for Affordable Approaches to Cancer

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

A Memorandum of Understanding (MoU) for the partnership between Department of Biotechnology and Cancer Research UK for the India-UK India-UK Cancer Research Initiative was signed today in New Delhi.The India-UK Cancer Research Initiative is a collaborative 5-year bilateral research initiative...

Read More

“MAA – Mothers’ Absolute Affection” programme started to improve breastfeeding practices in the coun

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

“The Health Ministry has taken up several focused and targeted schemes for addressing nutrition challenges in the country in a convergence mode with the other Ministries.We have focussed on Immunisation, detection and supplementation.” This was stated by Shri J P...

Read More

Accreditations